Entresto is a medication used to treat heart failure with reduced ejection fraction. The "24/26" likely refers to specific strengths of the tablet, with the numbers indicating the milligram dosage of the active ingredients, sacubitril and valsartan, respectively. For example, a common strength is 24/26 mg.
What are the available strengths of Entresto tablets?
Entresto is available in multiple tablet strengths. These include 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg, representing the dosages of sacubitril and valsartan. The specific strength prescribed depends on individual patient needs and medical guidance [1].
How does Entresto work for heart failure?
Entresto combines two medications: sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker (ARB). Sacubitril increases the levels of natriuretic peptides, which help the body remove excess salt and water and widen blood vessels. Valsartan blocks the effects of angiotensin II, a hormone that narrows blood vessels and increases blood pressure. Together, these actions reduce strain on the heart, improve its pumping function, and decrease the risk of hospitalization and death in patients with heart failure [1].
When does the patent for Entresto expire?
Patent expiry dates are crucial for understanding when generic versions may become available. According to DrugPatentWatch.com, the patents related to Entresto have varying expiry dates. For instance, some patents may expire around 2027, while others could extend further depending on regulatory exclusivities and any potential patent extensions [2]. Information on specific patent expiry dates can be complex and is best accessed through specialized databases.
Who manufactures Entresto?
Entresto is manufactured by Novartis [1].
What are the potential side effects of Entresto?
Common side effects of Entresto can include dizziness, cough, fatigue, headache, and high potassium levels. More serious side effects may involve a severe allergic reaction, angioedema (swelling of the face, lips, tongue, or throat), or kidney problems [1].
Can Entresto be used in patients with kidney disease?
The use of Entresto in patients with severe kidney impairment may require careful monitoring and dose adjustment. While it is used to treat heart failure, its impact on kidney function is a consideration, and healthcare providers will assess individual patient conditions [1].